Symbol Name ID |
Ptp4a3
protein tyrosine phosphatase 4a3 MGI:1277098 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Ptp4a3em1(IMPC)Mbp/Ptp4a3em1(IMPC)Mbp C57BL/6N-Ptp4a3em1(IMPC)Mbp/MbpMmucd |
abnormal behavior | J:211773 |
abnormal eye morphology | J:211773 | |
abnormal spleen morphology | J:211773 | |
decreased anxiety-related response | J:211773 | |
decreased thigmotaxis | J:211773 | |
hydrometra | J:211773 | |
hyperactivity | J:211773 | |
microphthalmia | J:211773 | |
small spleen | J:211773 | |
Ptp4a3tm1.1Geh/Ptp4a3tm1.1Geh involves: 129S1/Sv * 129X1/SvJ * C57BL/6J |
decreased body mass index | J:194458 |
decreased body weight | J:194458 | |
decreased incidence of tumors by chemical induction | J:194458 | |
decreased tumor growth/size | J:194458 | |
preweaning lethality, incomplete penetrance | J:194458 | |
Ptp4a3tm1.2Xhan/Ptp4a3tm1.2Xhan involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * FVB/N |
decreased circulating glucose level | J:197019 |
normal homeostasis/metabolism phenotype | J:197019 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/17/2024 MGI 6.24 |
|
|